Bioqual IncOTC Pink - Current Information:BIOQ
- LAST PRICE67.5000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots51.0000/ 1
- Ask / Lots67.5000/ 1
- Open / Previous Close--- / 67.5000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bioqual Inc | 60.4M | 126.2x | -25.28% |
MEI Pharma Inc | 18.5M | -0.4x | --- |
Sorrento Therapeutics Inc | 1.4M | 0.0x | --- |
Champions Oncology Inc | 61.9M | -17.0x | --- |
MDxHealth SA | 93.1M | -1.2x | --- |
Precision BioSciences Inc | 55.7M | 9.6x | --- |
Company Information
BIOQUAL, Inc. provides contract research services primarily focused on animal models of human diseases including acquired immunodeficiency syndrome (AIDS), influenza, respiratory syncytial virus (RSV) infection, coronavirus infections (including COVID-19), flavivirus infections (including Zika and Dengue), malaria, hepatitis, cancer, and other infectious diseases. It also performs in vitro contract research services. It is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its model services also include syngeneic mouse tumor allograft and select human cell line derived xenograft (CDX) models, and it offers GLP-compliant preclinical testing services in various small animal models. It provides its services to the federal government, universities and the life science and pharmaceutical industries.
Contact Information
- Headquarters
- 9600 Medical Center Drive, Suite 101ROCKVILLE, MD, United States 20850-3336
- Phone
- 240-404-7654
- Fax
- 240-404-7664
Executives
- Chairman of the Board, President, Chief Executive Officer
- Mark Lewis
- Chief Financial Officer
- Charles Kirk
- Chief Scientific Officer
- Hanne Elyard
- Vice President - Operations
- MITCH FRANKLIN
- Vice President - Facility Operations, Director - Information Technology
- Chander Sarma
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $60.4M |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 894.4K |
Dividend Yield | 0.74% |
Annual Dividend Rate | 0.5000 USD |
Ex-Dividend Date | 10-07-24 |
Pay Date | 10-28-24 |
Beta | -0.39 |
EPS | --- |
Book Value | $42.05 |
P/E Ratio | 126.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
